HHS Secretary Alex Azar on Thursday (Feb. 6) touted falling drug prices and his department’s work on drug imports, and he said drug pricing legislation is a top priority, but his State of the Department address did not mention HHS’ biggest potential initiative: tying Medicare reimbursement to international drug prices. He also left out the surprise medical billing legislation that the White House has been working on with Congress. Azar gave his State of the Department address two days after...